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know whether or not the RIVAL trial increased the TR approach for PCI in
patients with acute MI.
Methods: A total of 21,822 patients enrolled for about six years in the Korea Working
Group on Myocardial Infarction Registry were compared between before and after the
publication of the RIVAL trial. Pre-RIVAL group was consisted of 20,155 (96.5%)
patients and post-RIVAL group 767 (3.5%) patients.
Results: Compared to pre-RIVAL group, TR approach was significantly higher in
post-RIVAL group (18.2% vs 23.7%, p0.0001). Procedural success was not different in
pre- and post-RIVAL group (99.0% vs 98.3%) nor was vascular and bleeding complica-
tions (0.21% vs 0.1%). However, compared to TF approach, procedure-related all
complications were significantly lower in TR approach in both pre-RIVAL group (13.3%
vs 5.0%, p0.001) and post-RIVAL group (16.0% vs 4.9%, p0.001). In the subgroup
of ST-segment elevation MI (STEMI), TR approach was significantly higher in post-
RIVAL group (16% vs 22%, p0.001). In the subgroup of elderly patients80 years old,
TR approach was not different in pre- and post-RIVAL group (17.9% vs 13.5%, p0.285)
nor was in the female patients (16.0% vs 19.8%, p0.142).
Conclusions: This study shows that, in the era of post-RIVAL trial, the use of TR
approach for PCI was significantly increased in patients with acute MI as well as in
patients with STEMI.
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Background: Radial artery occlusion (RAO) is an infrequent complication of transradial
approach catheterization, but its incidence varies from 1 to 10%. One of predictive factors
is a non patent hemostasis. The purpose of our study was to evaluate radial patency by
Doppler after using a TR Band™ (TERUMO) in real life.
Methods: 574 patients were consecutively included in this european multicentric registry
with 8 centers. All patients received a vasodilator and heparin 	 cocktail 
 and
underwent cardiac catheterization using 5F or 6F introducer sheath and catheters.
Hemostasis was achieved for all patients with a radial compression device (TR Band™),
applied after sheath removal, with the same protocol for set up and removal allowing
flow-limiting compression and a short duration. RAO was evaluated by clinical and
Doppler with and without ulnar compression at 24 hours.
Results: With a majority of right radial approach, coronary angiography was performed
in 62% of cases. 6 Fr was used in 211 patients (37%) and a previous radial approach done
in 25% of cases. Compression pain evaluation on scale was low (2.3 2.4). Any major
site complication was observed, only 11.4% of small hematoma without transfusion or
surgical repair. Radial pulse was clinical patent in 98.5%. Doppler RAO occurred in 3.8%
(n 22). Univariate statistical analysis identified as significant predictors of RAO: no-use
of profile sheath (p  0.001), no pulse after TR Band™ withdrawal (p  0.001) and a
procedure performed by a young radialist physician (p 0.022). RAO was more frequent
with large sheath use and after previous radial approach, but not statistically significant.
Conclusions: Because one the most important RAO predictor factors is the maintain of
radial patency during hemostatic compression, TR Band™ device with its flow-limiting
compression allows to reduce early radial artery occlusion as confirmed by DRABAND
study, with only 3.8% incidence. We have also shown importance of quality sheath choice
avoiding radial occlusion complication.
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Background: Surgical cut-down has been a primary approach for arterial access to place
large caliber 22 or 24 Fr sheath used for commercially available transfemoral (TF)
transcatheter aortic valve replacement (TAVR) system in the US. The complete percu-
taneous arterial access and closure was recently introduced as an alternative approach for
arterial access/closure with acceptable safety. However, there has been no study
comparing these two approaches regarding acute clinical outcomes post TF TAVR.
Methods: In 230 patients who underwent TF TAVR using the Edward Sapien heart valve
that requires either 22 Fr or 24 Fr sheath for device deployment, 96 had complete
percutaneous approach using “pre-closure” technique and 134 by surgical cut-down/repair
for arterial access/closure of the device deployment. Immediate success of vascular
access/closure, associated complications and clinical outcome were compared.
Results: Acute success of access and closure was similar between the groups. While
overall access related event was similar, significant stenosis or dissection at the access site
was more frequently observed in the percutaneous group compared to the surgical group
(10.4 % vs. 3.0 %, p  0.020). These were successfully treated with immediate
percutaneous or surgical endovascular intervention. Contrary, compared to the percuta-
neous group, the wound site infection that required either prolonged antibiotics course or
surgical debridement occurred more frequently in the surgical group (1% vs. 6.7%, p 
0.023). While no difference was seen in major vascular complication and bleeding, the
percutaneous group received less frequent transfusion of packed red blood cell less than
or equal to 3 units (30.2 % vs. 43.3% for percutaneous group vs. surgical group, p 
0.044). Median hospital stay was significantly shorter in the percutaneous group (3 days
vs. 4 days for the percutaneous group vs. the surgical group, p  0.008).
Conclusions: Compared to the surgical approach, the complete percutaneous approach
for arterial access/closure of TF TAVR deployment system is feasible with acceptable
safety and potential clinical benefit.
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Background: The complete percutaneous access/closure has been introduced as an
alternative approach for surgical cut-down for placement of large caliber sheath in
transfemoral (TF) transcatheter aortic valve replacement (TAVR). However, incidence of
associated major vascular complication (VC), its anatomic characteristics and manage-
ment mode remains uncertain.
Methods: Using the pre-closure technique by deployment of two PerClose Proglide
devices (Abbott Vascular Inc., Santa Clara, California), 118 patients underwent complete
percutaneous approach for placement of either a 22 or 24 Fr sheath for TF TAVR using
the first generation Edwards-Sapien valves (23mm or 26mm diameter). Incidence of
immediate major VC defined by VARC, its angiographic location and success rate of
subsequent endovascular or surgical intervention was assessed.
Results: Major VC occurred in 14.4% of the patients (17 out of 118 cases). Dissection
or perforation of iliac artery was the most common form of the major VA (53%; 9 out of
17). Six cases developed major VC at the puncture site in common femoral artery (one
perforation and 5 stenoses). Two of these cases also had dissection in the separate site
(both at the bifurcation of external and internal iliac artery). All these were successfully
treated with peripheral endovascular intervention. Two other cases required surgical
intervention. One case with ruptured lower abdominal aorta was treated by both
endovascular intervention and surgical repair, and the other that has difficulty of sheath
removal underwent emergent iliofemoral bypass surgery. Compared to the patients
without major VC, the patients with major VC received more frequent blood transfusion
(28% vs. 71%, p 0.0008). However, there was no significant difference in mean length
of hospital stay (4.6  6.9 days vs. 4.8  3.7 days) and 30-day mortality (3.0% vs 5.9%
for no major VC vs. Major VC).
Conclusions: Iliofemoral artery was the most common site of major VC in TF TAVR
with percutaneous access/closure for device access for the first generation Edwards-
Sapien valves.The majority of them can be successfully managed by immediate
endovascular intervention and supportive therapy without affecting acute clinical out-
comes.
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Background: Despite improved clinical outcomes with the transradial access in STEMI,
the data on health related quality of life (HRQoL) is still limited. The aim was to
understand the HRQoL depending on the selected vascular approach.
Methods: 100 STE ACS individuals admitted for PCI were randomized to transfemoral
(TF, n48) or transradial (TR, n52) approach. A EQ-5D, visual analog scale (VAS) and
MacNew instruments were used to assess the HRQoL.
Results: The baseline HRQoL was indifferent (TF vs. TR). Two hours after PCI the
HRQoL improved (VAS: 50,2 vs. 70,1, p0,05). The mobility, self-care and pain were
impaired in the TF vs. TR (p0,01). Over next three days these domains improved and
differences equalized between groups. There was no difference of the total HRQoL on day
three as by VAS (72,1 vs.69,0), EQ-5D and MacNew (5,3 vs. 4,5), despite for lower
scores in emotional domain in the TF vs. TR (4,18 vs. 5,11, p0,05).
Conclusions: The TF approach is associated with lower HRQoL early after PCI and
improves within days after the procedure. An impaired emotional status noticed in TF
group needs to be studied in larger trials. The TR access should be preferred when patients
satisfaction is taken into account.
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Trans-
radial
Trans-
femoral
Hazard
ratio p
VAS_baseline 49.81 50.57 1.02 0.895
VAS_3h 72.26 67.52 1.15 0.348
EQ-5D_mobility_3h 2.22 2.74 1.93 0.008
EQ-5D_self-care_3h 1.85 2.43 1.48 0.003
EQ-5D_pain_3h 1.37 1.7 1.29 0.034
VAS_4d 72.11 69 2.09 0.603
EQ-5D_mobility_4d 1.26 1.22 1.47 0.805
EQ-5D_self-care_4d 1.21 1.11 2.74 0.502
EQ-5D_pain_4d 1.42 1.5 1.39 0.673
MacNew_emotional 5.12 4.19 1.12 0.019
MacNew_total 5.27 4.51 1.02 0.088
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Background: Various methods of hemostasis have been developed for large 22 to 24Fr
femoral vein accesses for structural heart disease. Manual compression (MC) is uncom-
fortable whilst a subcutaneous stitch (SCS), which too is uncomfortable to remove, and a
double Perclose (DPC; Abbott Vascular Devices, CA) closure enables immediate
hemostasis. This study is to determine the effectiveness and safety of these methods.
Methods: 155 patients (mean age 7017years; 60(38%) female) underwent 158 valvular
therapies with the MitraClip device [n147, 93%] (Abbott Vascular, Santa Clara, CA),
Melody [n 2, 1%] (Medtronic Inc., Minneapolis, MN) or Edwards SAPIEN [n 9, 6%]
(Edwards Lifesciences LLC, Irvine, CA) valves. There were 24(16%) SCS and 99(62%)
DPC, and 35(22%) MC.
Results: There were 8(5%) access site complications (ASC): 4/35(11%) in MC (2
hematoma 1cm but 5cm, 1 hematomas 5cm requiring 2U of blood, 1 arterial-
venous fistula), 1/24(4%) in SCS (1 bleeding site requiring 1U of blood), and 3/99(3%)
in DPC (1 femoral vein thrombosis, 1 hematoma 1cm but 5cm, 1 hematoma 5 cm
requiring 2U of blood). The frequency of ASC between methods was not significantly
different (MC vs. SCS p0.33, MC vs. DPC p0.06, SCS vs. DPC p0.78). Median
length of stay was 1.01.1 days and was similar to patients that developed ASC (p0.09)
and between groups (p0.23). Protamine (median dose 3018mg) use did not influence
the frequency of ASC (2/8 protamine use with ASC vs 6/8 without ASC, p0.29). Post
procedure hemoglobin and hematocrit drop was significant (1.41.0g/dL and 4.23.5%;
both p0.01) and by comparison, this decline was significantly less for SCS
(0.71.2g/dL and 1.93.9%; both p0.01). DPC required additional strategies (like a
SCS) to attain immediate hemostasis more than SCS (26/99 (26%) vs. 1/24 (4%),
p0.02). Overall there were no in-hospital deaths, ASC related deaths and wound
infections at follow-up (mean 2018months).
Conclusions: Femoral vein closure for large 22 to 24Fr accesses, with either the SCS or
DPC method enables immediate hemostasis and reduces patient discomfort, without
compromising safety.
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Background: Same-day discharge after elective percutaneous coronary interventions
(PCI) allows a decrease in length of hospital stay, waiting list and costs with increased
patient satisfaction, but data regarding clinical features of the population with potential
benefit and safety are limited.
Methods: A consecutive group of patients who underwent elective PCI and considered
suitable for same-day discharge over a period of 4 years were enrolled. Unstable patients
with left main disease, left ventricular ejection fraction  45%, non-use of dual
antiplatelet therapy, use of oral anticoagulants or inability to reach the PCI-center within
60 minutes were excluded. Patients were examined 6 hours post-PCI and discharged if
there were no procedural complications. Clinical follow-up was carried out in all patients
after 7 days from discharge, and at 1-month and 1-year.
Results: After 981 potentially ambulatory-PCI procedures, 417 patients (42.5%) were
discharged as day cases. PCI procedures were performed by transradial (89%), trans-
femoral (9.4%), or transcubital (1.6%) approach. Mean age was 6510 years (80% male),
50% active smokers, and 27% diabetics. Most patients (62%) lived in the city area (50
km away from the PCI-hospital). Procedural success was achieved in 100% of patients.
In over 85% of patients one or two lesions in one or two vessels were treated. The mean
procedure time, mean post-PCI observation time, and mean length-of-stay after PCI were
5822 min, 6.561.24 hrs, and 10.351.41 hrs, respectively. During the procedure,
vascular complications related to the radial route were found in 9 (2.1%) patients, and
crossover from transradial to transfemoral was needed in 6 (1.4%) of patients. At 7 days
follow-up, 2 patients developed mild size hematoma on radial access site and 1 patient on
femoral access site, without any other vascular complications or major bleeding. There
were no deaths or myocardial infarction within 7 days of discharge. The 1-year mortality
rate was very low (0.2%, 1 patient).
Conclusions: Same-day discharge after elective PCI is feasible and safe with a
remarkable 1-year outcome. Its application and benefits could be extended to a broader
population of patients.
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Background: In the UK, there has been a significant change in choice of access site for
PCI driven by the desire to reduce access site complications. This has become increasingly
important with the shift to more acute PCI with the use of more potent anti-thrombotic
agents. In view of the the rapid uptake of transradial access in the UK we sought to assess
changes in outcome using nationally collected data from the British Cardiovascular
Intervention Society database.
Methods: This study includes data collected by the British Cardiovascular Intervention
Society under the auspices of the Central Cardiac Audit Database. We performed a
retrospective analysis of the BCIS database between January 2006 and December
2010.The data was split into 2 cohorts based on access site: either radial or femoral (mixed
access site use and other access sites were excluded from the analysis).
Results: Of the 370,238 procedures recorded, 223,476 (60.4%) used only transferral
access (TFA) and 124,616 (33.7%) used only transradial access (TRA). Data was missing
or mixed access was used in 22,146 (6%) of procedures. Between 2006 and 2010 TRA
for PCI increased from 17.1% to 50.8%. Over the same period, PCI for ACS increased
from 47% to 61% of procedures. 30 day mortality was 1.9% in the TFA group and 1%
in the TRA group (p  0.001). The incidence of patients presenting with cardiogenic
shock was significantly higher in the TFA group (2.1% vs 0.9%, p0.001). With shocked
and intra-aortic ballon pump (IABP) treated patients excluded, TRA remained indepen-
dently associated with a reduction in 30 day mortality (HR 0.65, CI 0.60-0.70: p0.0001)
in a multivariate analysis.
Conclusions: The majority of PCI in the UK is now undertaken using radial access. In
this large observational study, there is an association between TRA and lower 30 day
mortality. The association persists even when shock and IABP treated patients are
excluded.
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Background: Transradial approach is used as an alternative to transfemoral approach for
coronary angiography (CA) and primary coronary intervention (PCI). Transradial ap-
proach results in less access site bleeding, immediate ambulation after the procedure,
reduced length of stay and costs, less pain and improved patient comfort. However, it has
been suggested that transradial approach can lead to increased incidence of radial artery
occlusion, not allowing for repeated catheterizations from the same artery. There is limited
data on the feasibility, safety and efficacy of repeated transradial (rTR) catheterization
from the same artery. We evaluated the incidence of failure and major complications
during rTR catheterization.
Methods: We performed 3.857 catheterizations with various indications and access sites
at the American Heart Institute, in Nicosia-Cyprus, between Jan 2006 and Dec 2009. In
our center, we established TR catheterization as the routine method for elective, urgent
and emergency procedures (primary or rescue PCI). Baseline characteristics (e.g.
sociodemographics, underlying disease, smoking, prior CABG), procedural success rates
and major complications were recorded.
Results: Right rTR catheterization was attempted in 92 patients. Repeated access to the
right radial site was not possible in only 2 patients, due to poor pulse (n1), and inability
to advance the wire (n1). In 84 patients right rTR was successfully performed twice, and
in 6 patients 3 times. No major access site complications were noted in any of the above
procedures.
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